Treatment with brepocitinib at 30 and 60 mg daily outperforms placebo at relieving signs and symptoms of psoriatic arthritis (PsA), with a safety ... Treatment with brepocitinib at 30 and…
Self-reported sleep problems are common among patients with psoriatic arthritis (PsA) and have a significant impact on quality of life, ... Self-reported sleep problems are common among patients with psoriatic…
Surprising Complications From Psoriatic Arthritis. Your joints and skin aren't the only parts of your body that this inflammatory disease can target. Surprising Complications From Psoriatic Arthritis. Your joints…
A new clinical trial shows potential for the drug brepocitinib to treat psoriatic arthritis, reducing symptoms by as much as 20%. A new clinical trial shows potential for the…
The Report offers a deep dive into the Active Psoriatic Arthritis market landscape, presenting an in-depth analysis of key market trends, ... The Report offers a deep dive into the…
Secukinumab and adalimumab have similar efficacy in the treatment of enthesitis in psoriatic arthritis (PsA), according to study findings ... Secukinumab and adalimumab have similar efficacy in the treatment of…
... with rheumatic disease sheds light on the apparent differences in impact on quality of life between psoriatic arthritis and rheumatoid arthritis. ... with rheumatic disease sheds light on…
THURSDAY, May 18, 2023 (HealthDay News) -- For patients with moderately to severely active psoriatic arthritis, the tyrosine kinase 2/Janus kinase ... THURSDAY, May 18, 2023 (HealthDay News) -- For…
Arthritis & Rheumatology publishes the highest quality basic and clinical research related to the rheumatic diseases, encompassing a wide range of ... Arthritis & Rheumatology publishes the highest quality basic…
Mease, P., et al. (2023) Efficacy and Safety of Tyrosine Kinase 2/Janus Kinase 1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb ... Mease, P., et al. (2023) Efficacy…